Danaher Corporation Opens Joint Office in Beijing's Chaoyang District
Company

Danaher Corporation Opens Joint Office in Beijing’s Chaoyang District

WuXi Biologics Partners with Sino Biopharmaceutical for First-in-Class Monoclonal Antibody Development
CompanyDeals

WuXi Biologics Partners with Sino Biopharmaceutical for First-in-Class Monoclonal Antibody Development

Hainan Free Trade Port Gets Green Light for Temporary Import of Special Medical Foods
Policy / Regulatory

Hainan Free Trade Port Gets Green Light for Temporary Import of Special Medical Foods

GenFleet Therapeutics Submits IPO Application to HKEX, Backed by CITIC Securities
Company

GenFleet Therapeutics Submits IPO Application to HKEX, Backed by CITIC Securities

Overwhelming Shareholder Support for Hengrui Pharmaceuticals' H-Share IPO
Company

Overwhelming Shareholder Support for Hengrui Pharmaceuticals’ H-Share IPO

Dynamiker Biotechnology Receives Approval for IPO on Beijing Stock Exchange
Company

Dynamiker Biotechnology Receives Approval for IPO on Beijing Stock Exchange

MicroPort Endovascular MedTech's Castor® Branched Stent Wins China Patent Gold Award
Company

MicroPort Endovascular MedTech’s Castor® Branched Stent Wins China Patent Gold Award

Daiichi Sankyo and AstraZeneca Withdraw EU Application for Datopotamab Deruxtecan in Lung Cancer
CompanyDrug

Daiichi Sankyo and AstraZeneca Withdraw EU Application for Datopotamab Deruxtecan in Lung Cancer

AstraZeneca China Announces Structural Adjustments to Oncology Business Divisions
Company

AstraZeneca China Announces Structural Adjustments to Oncology Business Divisions

Beijing Releases List of Novel Drugs and Technologies Exempt from CHS-DRG Payment Scheme
CompanyDrug

Beijing Releases List of Novel Drugs and Technologies Exempt from CHS-DRG Payment Scheme

Johnson & Johnson Secures Licensing Deal with Kaken Pharmaceutical for STAT6 Program
CompanyDeals

Johnson & Johnson Secures Licensing Deal with Kaken Pharmaceutical for STAT6 Program

Ascentage Pharma Announces Secondary Offering on Nasdaq, Expanding Global Reach
CompanyDeals

Ascentage Pharma Announces Secondary Offering on Nasdaq, Expanding Global Reach